Viewing Study NCT01535261

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-05-19 @ 1:13 PM
Study NCT ID: NCT01535261
Status: COMPLETED
Last Update Posted: 2016-10-27
First Post: 2012-02-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Edema View
None Central Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ophthalmology View
None Ranibizumab View
None Central Retinal Vein Occlusion View